期刊
CURRENT DRUG METABOLISM
卷 17, 期 8, 页码 755-762出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389200217666160714095722
关键词
Cancer immunotherapy; dendritic cells; immunosuppression; macrophages; nanoparticles; tumor microenvironment; vaccine
资金
- Natural Science Foundation of China [81503018]
- Sichuan University Startup Foundation for Talents [2082204174131]
Background: Rapid advancement over the past few decades in cancer immunotherapy provides life-saving options for cancer patients. However, commonly used strategies including small molecules and various biomacromolecule-based therapeutics suffer from serious off-target toxicity and a lack of stability in the circulation. Objective: To overcome these problems, various nanoparticulate delivery systems have been developed to achieve controlled and sustained drug release, improved stability and pharmacokinetic profiles, and tumor specificity to reduce off-target adverse effects. Method: We reviewed representative studies on multiple nanoparticulate platform systems for delivering therapeutics in cancer immunotherapy, and discussed the advances and perspectives for the future development of novel therapeutics in cancer immunotherapy. Results and Perspectives: Nanoparticles for the controlled delivery of immune modulating agents represents a viable approach in cancer immunotherapy. Besides seeking novel carrier systems or new materials, efforts need to be contributed to delineating the impact of intrinsic properties of nanoparticles such as material composition, morphology, size distribution, charge, and stiffness in manipulating immune responses in cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据